| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Intellia Therapeutics, Inc. (NTLA) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 69 sells. NTLA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.01M | $14.47M | - | |
| Dir | 207.5K | $2.96M | - | |
| Dir | 134.7K | $1.92M | - | |
| VP | 121.2K | $1.73M | - | |
| VP | 101.5K | $1.45M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2021 | Goddard Glenn83 | EVP, Chief Financial Officer | Sale+OE | 20,000 | $151.05 | $3,021,056.08 | -65.3% | -17.7% | -61.7% | |
| Aug 4, 2021 | Sepp-Lorenzino Laura83 | EVP, Chief Scientific Officer | Sale+OE | 26,000 | $138.24 | $3,594,356.93 | -24.2% | -7.7% | -55.5% | |
| Jun 28, 2021 | Formela Jean Francois70 | Director | Sell | 553,376 | $132.73 | $73,448,878.91 | -13.8% | +10.6% | -61.0% | |
| Jun 14, 2021 | Formela Jean Francois70 | Director | Sell | 201,725 | $87.04 | $17,558,773.95 | -4.2% | +75.4% | -56.3% | |
| Apr 29, 2021 | Formela Jean Francois70 | Director | Sell | 4,513 | $85.43 | $385,545.59 | -0.6% | +70.0% | -38.8% | |
| Apr 28, 2021 | Formela Jean Francois70 | Director | Sell | 342,962 | $85.96 | $29,482,338.40 | -5.8% | +55.2% | -41.1% | |
| Apr 5, 2021 | Dorsa Caroline58 | Director | Sale+OE | 7,500 | $82.19 | $616,404.96 | -25.0% | +86.3% | -12.6% | |
| Apr 5, 2021 | Formela Jean Francois70 | Director | Sell | 800 | $84.98 | $67,984.00 | - | +86.3% | -12.6% | |
| Apr 1, 2021 | Leonard John M83 | President And CEO | Sale+OE | 38,209 | $83.64 | $3,195,661.00 | -2.7% | +102.2% | -4.9% | |
| Apr 1, 2021 | Rivera Jose E | EVP, General Counsel | Sale+OE | 50,455 | $82.46 | $4,160,559.05 | -1.6% | +102.2% | -4.9% |